Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice

Molecular Nutrition and Food Research

Volumn 55, Issue 4, 2011, Pages 606-612

  Yang, Chih Min ^a   Yen, Yeu Torng ^a   Huang, Chin Shiu ^b   Hu, Miao Lin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

Author keywords

carotene; Insulin like growth factor binding protein 3; Lycopene; Prostate cancer; Vascular endothelial growth factor

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; BETA CAROTENE; CAROTENOID; CYCLINE; LYCOPENE; SOMATOMEDIN BINDING PROTEIN 3; VASCULOTROPIN;

ANIMAL; ARTICLE; BLOOD; CARCINOMA; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG SCREENING; HUMAN; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; RANDOMIZATION; TIME; TUMOR CELL LINE; TUMOR VOLUME;

ANDROGENS; ANIMALS; ANTICARCINOGENIC AGENTS; BETA CAROTENE; CARCINOMA; CAROTENOIDS; CELL LINE, TUMOR; DIETARY SUPPLEMENTS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MICE; MICE, NUDE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATIC NEOPLASMS; RANDOM ALLOCATION; TIME FACTORS; TUMOR BURDEN; VASCULAR ENDOTHELIAL GROWTH FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 79953309675     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000308     Document Type: Article

References (39)

1. American Cancer Society, Cancer facts and figures 2009. Atlanta, Georgia 2009.
2. Crawford, E. D., Understanding the epidemiology, natural history, and key pathways involved in prostate cancer. Urology 2009, 73, S4-S10.
3. Roddam, A. W., Allen, N. E., Appleby, P., Key, T. J., Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J. Natl. Cancer Inst. 2008, 100, 170-183.
4. Kelloff, G. J., Crowell, J. A., Steele, V. E., Lubet, R. A. et al., Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J. Nutr. 2000, 130, 467S-471S.
5. Giovannucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J. et al., Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst. 1995, 87, 1767-1776.
6. Clinton, S. K., Lycopene: chemistry, biology, and implications for human health and disease. Nutr. Rev. 1998, 56, 35-51.
7. Olson, J. A., Krinsky, N. I., Introduction: the colorful, fascinating world of the carotenoids: important physiologic modulators. FASEB J. 1995, 9, 1547-1550.
8. Giovannucci, E., A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp. Biol. Med. (Maywood) 2002, 227, 852-859.
9. Clinton, S. K., Emenhiser, C., Schwartz, S. J., Bostwick, D. G. et al., cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol. Biomarkers Prev. 1996, 5, 823-833.
10. Gann, P. H., Ma, J., Giovannucci, E., Willett, W. et al., Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 1999, 59, 1225-1230.
11. Levy, J., Bosin, E., Feldman, B., Giat, Y. et al., Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr. Cancer 1995, 24, 257-266.
12. Livny, O., Kaplan, I., Reifen, R., Polak-Charcon, S. et al., Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells. J. Nutr. 2002, 132, 3754-3759.
13. Huang, C. S., Liao, J. W., Hu, M. L., Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. J. Nutr. 2008, 138, 538-543.
14. Tang, L., Jin, T., Zeng, X., Wang, J. S., Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J. Nutr. 2005, 135, 287-290.
15. Huang, C. S., Chuang, C. H., Hu, M. L., Effects of lycopene supplementation on plasma and tissue lycopene levels in various rodent strains. Int. J. Vitam. Nutr. Res. 2006, 76, 377-384.
16. Su, Q., Rowley, K. G., O'Dea, K., Stability of individual carotenoids, retinol and tocopherols in human plasma during exposure to light and after extraction. J. Chromatogr. B Biomed. Sci. Appl. 1999, 729, 191-198.
17. Jia, L., Shang, Y. Y., Li, Y. Y., Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice. World J. Gastroenterol. 2008, 14, 4377-4382.
18. Liu, J. F., Lo, A., Yang, F. L., Wang, T. Y. et al., Analysis of vitamin E, selenium, and other nutrients in planed balanced diets in Taiwan. Nutr. Sci. J. 2002, 27, 221-231.
19. Chen, L., Stacewicz-Sapuntzakis, M., Duncan, C., Sharifi, R. et al., Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J. Natl. Cancer Inst. 2001, 93, 1872-1879.
20. Shao, A., Hathcock, J. N., Risk assessment for the carotenoids lutein and lycopene. Regul. Toxicol. Pharmacol. 2006, 45, 289-298.
21. Amir, H., Karas, M., Giat, J., Danilenko, M. et al., Lycopene and 1, 25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr. Cancer 1999, 33, 105-112.
22. Karas, M., Amir, H., Fishman, D., Danilenko, M. et al., Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr. Cancer 2000, 36, 101-111.
23. Fornelli, F., Leone, A., Verdesca, I., Minervini, F., Zacheo, G., The influence of lycopene on the proliferation of human breast cell line (MCF-7). Toxicol. In Vitro 2007, 21, 217-223.
24. Huang, C. S., Fan, Y. E., Lin, C. Y., Hu, M. L., Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. J. Nutr. Biochem. 2007, 18, 449-456.
25. Huang, C. S., Shih, M. K., Chuang, C. H., Hu, M. L., Lycopene inhibits cell migration and invasion and upregulates Nm23-H1 in a highly invasive hepatocarcinoma, SK-Hep-1 cells. J. Nutr. 2005, 135, 2119-2123.
26. Kimura, G., Kasuya, J., Giannini, S., Honda, Y. et al., Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells. Int. J. Urol. 1996, 3, 39-46.
27. Mohseni-Zadeh, S., Binoux, M., Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action. Endocrinology 1997, 138, 5645-5648.
28. Kim, H. S., Ingermann, A. R., Tsubaki, J., Twigg, S. M. et al., Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Res. 2004, 64, 2229-2237.
29. Singh, R. P., Tyagi, A. K., Dhanalakshmi, S., Agarwal, R., Agarwal, C., Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3. Int. J. Cancer 2004, 108, 733-740.
30. Folkman, J., Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 2002, 29, 15-18.
31. Kim, K. J., Li, B., Winer, J., Armanini, M. et al., Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362, 841-844.
32. Ferrer, F. A., Miller, L. J., Andrawis, R. I., Kurtzman, S. H. et al., Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J. Urol. 1997, 157, 2329-2333.
33. Gridley, D. S., Andres, M. L., Slater, J. M., Enhancement of prostate cancer xenograft growth with whole-body radiation and vascular endothelial growth factor. Anticancer Res. 1997, 17, 923-928.
34. Razny, U., Polus, A., Kiec-Wilk, B., Wator, L. et al., Angiogenesis in Balb/c mice under beta-carotene supplementation in diet. Genes Nutr. 2010, 5, 9-16.
35. Dembinska-Kiec, A., Polus, A., Kiec-Wilk, B., Grzybowska, J. et al., Proangiogenic activity of beta-carotene is coupled with the activation of endothelial cell chemotaxis. Biochim. Biophys. Acta 2005, 1740, 222-239.
36. Guruvayoorappan, C., Kuttan, G., Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells. Integr. Cancer Ther. 2007, 6, 258-270.
37. Robbins, B. A., de la Vega, D., Ogata, K., Tan, E. M., Nakamura, R. M., Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch. Pathol. Lab. Med. 1987, 111, 841-845.
38. Weber, K. L., Doucet, M., Price, J. E., Baker, C. et al., Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice. Cancer Res. 2003, 63, 2940-2947.
39. Borel, P., Moussa, M., Reboul, E., Lyan, B. et al., Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J. Nutr. 2007, 137, 2653-2659.